Semaglutide News and Research

Latest Semaglutide News and Research

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

Exercise plays a crucial role in managing type 2 diabetes, offering potential benefits such as improved glycemic control. This study explores exercise recommendations and their impact on dietary, medication, and behavioral factors for optimal diabetes care.

5 Jul 2023

Ever-growing global diabetes burden exacerbated by large-scale inequity

Despite increased awareness and ongoing multinational efforts, diabetes is pervasive, exponentially growing in prevalence, and outpacing most diseases globally, according to a new Series published in The Lancet and The Lancet Diabetes & Endocrinology journals.

5 Jul 2023

Study calls for renaming of 'obesity' to better reflect the disease

We must change the way we talk about obesity to improve public understanding of the disease, according to a new study.

3 Jul 2023

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Multiple members of The Obesity Society (TOS) unveiled new research about several anti-obesity medications in development at this year's annual meeting of the American Diabetes Association (ADA) held June 23–26.

29 Jun 2023

McMaster research opens new possibilities to help people maintain weight loss after dieting

Researchers led by McMaster University professor Gregory Steinberg and postdoctoral research fellow Dongdong Wang have uncovered a key mechanism for promoting weight loss and maintaining the burning of calories during dieting.

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Diabetes is a progressive disease that affects one's ability to control blood sugar levels. For many patients, the condition becomes more severe over time and blood sugar levels grow more difficult to manage.

26 Jun 2023

Type 2 diabetes is frequently overlooked in clinical trials, analysis reveals

New analysis of official records from the National Institute of Health (NIH) have revealed that just 365,000 people took part in a clinical trial for Type 2 Diabetes in 2021, despite 37.3 million people in the US living with the condition - or more than 11% of the population.

24 Jun 2023

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Researchers evaluated the effectiveness of diabetic diets containing D-allulose among type 2 diabetes patients.

21 Jun 2023

Research reveals a potential gap in recommended care for people with obesity and overweight

By being undiagnosed or untreated, a significant fraction of people with obesity or overweight are not getting the recommended care, despite an increase in new treatment options, according to research being presented on June 17 at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

18 Jun 2023

Study: Some breast cancer drugs may lessen the effect of weight loss medications

Breast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presented Friday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.

15 Jun 2023

Slow your disenroll

The Biden administration this week pleaded with states to slow the post-pandemic removal of beneficiaries from their Medicaid rolls, as government data shows more than a million Americans have lost coverage since pandemic protections ended in April.

15 Jun 2023

Carb conundrum: debunking the link between pasta and obesity

Researchers reviewed existing data on the impact of diet patterns with high pasta content on body weight.

13 Jun 2023

Diabetes drug reduces alcohol drinking by more than half in rats

The medication semaglutide, which is currently used in the treatment of type 2 diabetes and obesity, might also be an effective medication for alcohol dependence.

7 Jun 2023

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

Orally administered semaglutide shows significant efficacy in reducing HbA1c and body weight in patients with type 2 diabetes compared to other treatments. The study includes a large number of participants from multiple trials.

7 Jun 2023

How does tirzepatide stimulate insulin secretion?

Tirzepatide, a drug approved for diabetes and on the fast track for approval as a weight loss therapy, works through a unique ability to activate two different mechanisms the body uses to control insulin secretion and energy balance, Duke Health researchers report.

6 Jun 2023

Many people living in the ‘diabetes belt’ are plagued with medical debt

Delores Lowery remembers vividly the day in 2016 when she was working in a weaving plant near her home in Bennettsville, South Carolina, and the world around her seemed to go dim.

30 May 2023

Do glucose-lowering medications have different effects on kidney outcomes?

Researchers evaluated the kidney outcomes in individuals with type 2 diabetes.

26 May 2023

Semaglutide News and Research

Latest Semaglutide News and Research

Timing, type, and frequency of exercise are crucial components for optimal glycemic control in type 2 diabetes

Ever-growing global diabetes burden exacerbated by large-scale inequity

Study calls for renaming of 'obesity' to better reflect the disease

TOS members unveil new research about anti-obesity medications at ADA annual meeting

McMaster research opens new possibilities to help people maintain weight loss after dieting

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Higher doses of oral semaglutide effective in lowering blood sugar and promoting weight loss

Type 2 diabetes is frequently overlooked in clinical trials, analysis reveals

Rare sugars in a diabetic diet: the efficacy of a D-allulose-containing diet in patients with type two diabetes

Research reveals a potential gap in recommended care for people with obesity and overweight

Study: Some breast cancer drugs may lessen the effect of weight loss medications

Slow your disenroll

Carb conundrum: debunking the link between pasta and obesity

Diabetes drug reduces alcohol drinking by more than half in rats

Oral semaglutide outperforms other medications in type 2 diabetes treatment, significantly reducing HbA1c and body weight

How does tirzepatide stimulate insulin secretion?

Many people living in the ‘diabetes belt’ are plagued with medical debt

Do glucose-lowering medications have different effects on kidney outcomes?

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Semaglutide News and Research

Latest Semaglutide News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in